<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Mastectomy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Mastectomy</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Mastectomy</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ava Kwong, MBBS, BSc, FRCS, FCSHK, FHKAM</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael S Sabel, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anees B Chagpar, MD, MSc, MA, MPH, MBA, FACS, FRCS(C)</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 20, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H374254741"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Mastectomy (complete removal of the tissue of the breast) is one option for the surgical treatment of breast cancer and the only surgical option for breast cancer risk reduction.</p><p>This topic will address the types, indications, techniques, and complications of mastectomy. Breast-conserving therapy for breast cancer and the surgical management of regional lymph nodes in breast cancer patients are reviewed separately. (See  <a class="medical medical_review" href="/d/html/807.html" rel="external">"Breast-conserving therapy"</a> and  <a class="medical medical_review" href="/d/html/813.html" rel="external">"Overview of management of the regional lymph nodes in breast cancer"</a> and  <a class="medical medical_review" href="/d/html/810.html" rel="external">"Overview of sentinel lymph node biopsy in breast cancer"</a>.)</p><p class="headingAnchor" id="H374254747"><span class="h1">SURGICAL ANATOMY</span><span class="headingEndMark"> — </span>The mature adult breast lies between the second and sixth ribs in the vertical axis and between the sternal edge and the midaxillary line in the horizontal axis. Breast tissue also projects into the axilla as the axillary tail of Spence. The breast is comprised of three major elements: skin, subcutaneous tissue, and breast tissue. (See  <a class="medical medical_review" href="/d/html/812.html" rel="external">"Breast development and morphology", section on 'Anatomy'</a>.)</p><p>The superficial pectoral fascia envelops the breast and is continuous with the superficial abdominal fascia (of Camper). The undersurface of the breast lies on the deep pectoral fascia, covering the pectoralis major and serratus anterior muscles. Connecting these two fascial layers are fibrous bands (the Cooper suspensory ligaments) that represent a natural means of support for the breast.</p><p>Axillary anatomy and the techniques of sentinel node biopsy and axillary dissection are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/805.html" rel="external">"Sentinel lymph node biopsy in breast cancer: Techniques"</a> and  <a class="medical medical_review" href="/d/html/14984.html" rel="external">"Technique of axillary lymph node dissection"</a>.) </p><p class="headingAnchor" id="H374254753"><span class="h1">INDICATIONS FOR MASTECTOMY</span></p><p class="headingAnchor" id="H374254759"><span class="h2">Breast conservation contraindicated or unsuccessful</span><span class="headingEndMark"> — </span>The criteria that preclude breast conservation are presented here briefly and addressed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/807.html" rel="external">"Breast-conserving therapy", section on 'Patient selection for BCT'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Inflammatory breast cancer (IBC). For patients with IBC, the standard of care is neoadjuvant chemotherapy followed by modified radical mastectomy and postmastectomy radiation therapy, even if the patient has a complete clinical response to neoadjuvant chemotherapy. (See  <a class="medical medical_review" href="/d/html/768.html" rel="external">"Inflammatory breast cancer: Clinical features and treatment"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Multicentric disease with two or more primary tumors in separate quadrants of the breast. However, ongoing research is assessing techniques that could permit breast conservation for selected multicentric diseases with a satisfactory cosmetic outcome. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Diffuse suspicious microcalcifications on mammography such that the extent of disease is not clearly evident. (See  <a class="medical medical_review" href="/d/html/808.html" rel="external">"Diagnostic evaluation of suspected breast cancer", section on 'Mammographic features of breast cancer'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A history of prior therapeutic radiation that included a portion of the affected breast, which, with the addition of whole breast radiation therapy (WBRT), would result in an excessively high total radiation dose to the chest wall. This includes patients who had prior breast radiation as well as those who received chest wall radiation for other reasons, such as mantle radiation for Hodgkin's lymphoma (see  <a class="medical medical_review" href="/d/html/4764.html" rel="external">"Second malignancies after treatment of classic Hodgkin lymphoma", section on 'Breast cancer'</a>). Ongoing studies are assessing partial breast irradiation alternatives to WBRT for these patients, which could permit breast conservation. (See  <a class="medical medical_review" href="/d/html/789.html" rel="external">"Radiation therapy techniques for newly diagnosed, non-metastatic breast cancer", section on 'Accelerated partial breast irradiation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pregnancy is an absolute contraindication to the use of breast irradiation; however, there are some patients in the later stages of pregnancy who, following surgery and/or chemotherapy, may safely defer radiation to after delivery, allowing for breast conservation. (See  <a class="medical medical_review" href="/d/html/786.html" rel="external">"Gestational breast cancer: Epidemiology and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inability to clear persistently positive resection margins after reasonable attempts at reexcision.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Breast conservation contraindicated or unsuccessful, as an example, large tumor size in relation to breast size. Although neoadjuvant systemic treatment has the potential to downstage large tumors and improve the chances for successful breast-conserving surgery, insufficient response to neoadjuvant chemotherapy or endocrine therapy requires mastectomy. Alternatively, oncoplastic surgery may permit breast conservation in this scenario. (See  <a class="medical medical_review" href="/d/html/14225.html" rel="external">"General principles of neoadjuvant management of breast cancer", section on 'Patient selection'</a> and  <a class="medical medical_review" href="/d/html/14976.html" rel="external">"Oncoplastic breast surgery"</a>.) </p><p></p><p class="headingAnchor" id="H374254765"><span class="h2">Patient preference</span><span class="headingEndMark"> — </span>Some patients may choose to have a mastectomy rather than breast-conserving therapy for various reasons, including a desire to avoid postoperative radiation, further screening, or biopsies. </p><p>When both breast-conserving surgery and mastectomy are clinically and oncologically acceptable, patients should be presented with the advantages and disadvantages of both approaches. This should include discussion of cosmetic concerns because breast-conserving surgery may result in unacceptable cosmetic results if the patient has a small amount of breast tissue. Discussion should also include a realistic risk assessment of the likelihood of a recurrence or second primary as studies have shown that many women grossly overestimate this risk. Careful review of the risks and benefits of both options, including the long-term complications of mastectomy, the limitations and complications of breast reconstruction, and the absence of a survival benefit from mastectomy, is critical for optimal shared decision making.</p><p class="headingAnchor" id="H374254771"><span class="h2">Breast cancer risk reduction</span><span class="headingEndMark"> — </span>For women without a personal history of cancer who carry a known deleterious mutation in a breast cancer susceptibility gene, such as <em>BRCA1/2, TP53, PTEN, STK11, CDH1</em>, or <em>PALB2</em>, bilateral prophylactic mastectomy reduces the risk of developing cancer by more than 90 percent [<a href="#rid1">1-3</a>]. Similarly, for those patients diagnosed with unilateral breast cancer and who harbor a mutation, a contralateral prophylactic mastectomy may be an option. However, the decision about whether to undergo such surgery is based on patient preference, given that with enhanced screening/surveillance, often incorporating magnetic resonance imaging (MRI), there is no demonstrable survival benefit to contralateral prophylactic mastectomy in this patient population. (See  <a class="medical medical_review" href="/d/html/758.html" rel="external">"Cancer risks and management of BRCA1/2 carriers without cancer"</a> and  <a class="medical medical_review" href="/d/html/94744.html" rel="external">"Contralateral prophylactic mastectomy"</a>.) </p><p class="headingAnchor" id="H374254777"><span class="h1">CHOICE OF MASTECTOMY</span><span class="headingEndMark"> — </span>Types of mastectomy used in modern breast surgery include modified radical mastectomy (MRM), simple (total) mastectomy, skin-sparing mastectomy (SSM), and nipple-areolar-sparing mastectomy (NSM). Radical mastectomy is a legacy procedure that is rarely indicated  (<a class="graphic graphic_figure graphicRef75503" href="/d/graphic/75503.html" rel="external">figure 1</a>). </p><p>Following mastectomy, breast reconstruction can commence at the same time ("immediate") or after the completion of cancer treatment ("delayed"). The timing of the planned reconstruction has important implications on the choice of mastectomy techniques [<a href="#rid4">4</a>]. (See  <a class="medical medical_review" href="/d/html/801.html" rel="external">"Overview of breast reconstruction", section on 'Timing of breast reconstruction'</a>.)</p><p class="headingAnchor" id="H1143620057"><span class="h2">Delayed or no reconstruction</span><span class="headingEndMark"> — </span>For patients who are not having immediate reconstruction, an MRM or simple mastectomy is performed. MRM includes level 1 and 2 axillary lymph node dissection and is utilized in patients undergoing mastectomy who have biopsy-proven axillary metastases or fail to map for sentinel lymph node biopsy. Clinically node-negative patients should undergo simple mastectomy and sentinel lymph node biopsy. (See  <a class="medical medical_review" href="/d/html/813.html" rel="external">"Overview of management of the regional lymph nodes in breast cancer"</a>.)</p><p class="headingAnchor" id="H374254789"><span class="h3">Modified radical mastectomy</span><span class="headingEndMark"> — </span>An MRM is a complete removal of the breast and the underlying fascia of the pectoralis major muscle, along with the level I and II axillary lymph nodes. Several randomized trials have documented equivalent survival rates with MRM compared with radical mastectomy, with less morbidity [<a href="#rid5">5-8</a>]. The equivalent survival outcome of the two procedures was further confirmed in an analysis of 3236 women enrolled in four randomized trials [<a href="#rid9">9,10</a>]. </p><p class="headingAnchor" id="H374254795"><span class="h3">Simple mastectomy</span><span class="headingEndMark"> — </span>A simple or total mastectomy also entails complete removal of the entire breast and the underlying fascia of the pectoralis major muscle. The only difference between MRM and a simple mastectomy is that the former includes a level 1 and 2 axillary dissection. With the emergence of sentinel node biopsy, simple mastectomy is performed more frequently than in the past. (See  <a class="medical medical_review" href="/d/html/810.html" rel="external">"Overview of sentinel lymph node biopsy in breast cancer"</a> and  <a class="medical medical_review" href="/d/html/805.html" rel="external">"Sentinel lymph node biopsy in breast cancer: Techniques"</a>.)</p><p class="headingAnchor" id="H2888059193"><span class="h2">Immediate reconstruction</span><span class="headingEndMark"> — </span>For patients planning either therapeutic or prophylactic mastectomy with immediate reconstruction, an SSM or NSM should be considered. The decisions regarding how much skin to preserve, whether the nipple-areolar complex (NAC) can be spared or removed, and the appropriate incisions to use require coordination between the breast surgeon and the plastic surgeon.</p><p>For most patients having mastectomy for prophylactic purposes (typically with immediate reconstruction), an SSM or NSM will most often provide the best cosmetic result. However, there are exceptions (eg, women with large, pendulous breasts or women wishing to be reconstructed to a larger cup size). </p><p class="headingAnchor" id="H374254801"><span class="h3">Skin-sparing mastectomy</span><span class="headingEndMark"> — </span>The SSM is a surgical technique in which the majority of the natural breast skin envelope is preserved [<a href="#rid11">11</a>]; by contrast, a conventional mastectomy incision (for MRM or simple mastectomy) removes a larger portion of the overlying skin. (See <a class="local">'Incisions'</a> below.)</p><p>The entire breast parenchyma and the NAC are excised. In some cases, the existing biopsy scar and/or the skin overlying the tumor is also excised. A reconstructive procedure is typically performed in the same setting as an SSM. Thus, the skin incision is planned with the plastic surgeon. </p><p>Preservation of the skin of the breast and the inframammary fold provides the reconstructed breast with a more natural shape and contour. The superior cosmetic result has resulted in the increasing popularity of this approach in both the United States and Europe [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/d/html/96115.html" rel="external">"Options for autologous flap-based breast reconstruction", section on 'General considerations and flap types'</a> and  <a class="medical medical_review" href="/d/html/801.html" rel="external">"Overview of breast reconstruction", section on 'Choice of reconstruction'</a>.)</p><p>Retrospective and prospective studies found that the local recurrence rates following an SSM range from 0 to 7 percent, comparable to those of a standard mastectomy, provided the dissection between the breast and the skin is meticulously performed [<a href="#rid13">13,14</a>]. In a meta-analysis of retrospective studies (median follow-up 37 to 101 months), no significant difference in local recurrence was identified between patients with an SSM and immediate reconstruction (n = 1104) and those undergoing a conventional mastectomy without reconstruction (n = 2635) [<a href="#rid14">14</a>]. </p><p>SSM is contraindicated for inflammatory breast cancer because of cancer cell invasion of the dermal lymphatics [<a href="#rid15">15</a>]. (See  <a class="medical medical_review" href="/d/html/768.html" rel="external">"Inflammatory breast cancer: Clinical features and treatment", section on 'Surgery'</a>.)</p><p class="headingAnchor" id="H374254807"><span class="h3">Nipple-areolar-sparing mastectomy</span><span class="headingEndMark"> — </span>An NSM differs from other mastectomy techniques in that it preserves the dermis and epidermis of the nipple but removes the major ducts from within the nipple lumen [<a href="#rid16">16</a>], whereas other techniques remove the NAC. If the nipple cannot be preserved, there is also an option of removing the nipple and preserving the areola (areolar-sparing mastectomy), which can also preserve the cosmetic outcome, particularly in women who do not have a sizable nipple [<a href="#rid17">17</a>]. </p><p>Historically, mastectomy has resected the NAC with the mammary gland because the NAC may harbor occult tumor cells in 5 to 12 percent of patients [<a href="#rid18">18</a>]. Over time, NSM for the treatment of breast cancer became more widely accepted [<a href="#rid19">19,20</a>]. Because this technique results in long skin flaps, it is primarily utilized for women with small- to moderate-sized breasts with minimal ptosis. NSM in a large breast risks flap and nipple necrosis, while NSM in a ptotic breast risks nipple necrosis and malposition [<a href="#rid21">21</a>].</p><p>Most retrospective studies of NSM have limited its use to women with small, peripherally located tumors (tumors &lt;2 cm with a tumor to NAC complex distance &gt;2 cm) without multicentricity [<a href="#rid22">22,23</a>]. However, some studies have suggested it may be reasonable in selected patients with larger tumors or tumors closer to the NAC as long as there is no direct involvement of the NAC [<a href="#rid24">24</a>]. </p><p>There are no randomized trials of NSM, and long-term follow-up in clinical series is limited [<a href="#rid24">24-28</a>]. Nevertheless, a 2018 systematic review and meta-analysis of 14 studies found no difference between NSM and SSM in five-year disease-free survival and mortality rates, and local recurrence rates were similar at 3.9 and 3.3 percent, respectively [<a href="#rid29">29</a>]. A 2015 meta-analysis of 20 studies also reported survival and local recurrence rates of NSM that were comparable to those of MRM and SSM [<a href="#rid30">30</a>]. </p><p>NSM may be particularly attractive for patients undergoing mastectomy for prophylaxis [<a href="#rid3">3</a>], although some mutation carriers may not be comfortable with leaving the NAC containing all of the terminal ducts, which have a small theoretical risk of harboring breast cancer. </p><p>In a retrospective study, a total of 548 risk-reducing NSMs in 346 <em>BRCA</em> carriers were performed at nine institutions [<a href="#rid31">31</a>]. With a median and mean follow-up of 34 and 56 months, respectively, no ipsilateral breast cancers occurred after prophylactic NSM. Using risk models for <em>BRCA1</em>/<em>2</em> mutation carriers, approximately 22 new primary breast cancers were expected without prophylactic NSM. Other studies with short or intermediate follow-up (three to four years) reached the same conclusions [<a href="#rid32">32-34</a>]. Long-term outcome data, however, are lacking.</p><p>The advantage of NSM over SSM is mainly aesthetic. Multiple studies have demonstrated the superior cosmetic outcomes of NSM over SSM [<a href="#rid26">26,35</a>]. Quality-of-life scores (particularly psychologic and sexual) were also higher after NSM [<a href="#rid36">36</a>]. This is in spite of the fact that nipple sensation is largely or completely lost after NSM [<a href="#rid37">37</a>] and increased complications such as nipple loss due to ischemia. (See <a class="local">'Nipple necrosis'</a> below.)</p><p>The eligibility criteria for NSM are evolving [<a href="#rid38">38</a>]. NSM is contraindicated in patients with inflammatory breast cancer, clinical or radiologic involvement of the NAC, nipple retraction, Paget disease, or bloody nipple discharge [<a href="#rid39">39,40</a>]. </p><p class="headingAnchor" id="H3855282321"><span class="h2">Radical mastectomy</span><span class="headingEndMark"> — </span>Radical mastectomy is rarely used in modern breast surgery. A radical (Halsted) mastectomy consists of en bloc removal of the breast, the overlying skin, the pectoralis major and minor muscles, and the entire axillary contents (level I, II, and III nodes). This extensive resection was originally proposed to provide a better chance of disease control than lumpectomy alone and was the standard of care for treating breast cancer for many years, largely in an era where systemic therapy was unavailable [<a href="#rid41">41</a>]. However, despite improved local control, the curative potential of this operation remained limited. In a series that followed 1438 women who had undergone radical mastectomy over 30 years, only 13 percent were free of disease, and 57 percent had died of breast cancer [<a href="#rid42">42</a>]. Attempts to further expand the field of resection by including the internal mammary nodes [<a href="#rid43">43</a>], known as an "extended radical mastectomy," failed to improve survival [<a href="#rid44">44</a>]. </p><p class="headingAnchor" id="H374254855"><span class="h1">PREOPERATIVE PREPARATION</span></p><p class="headingAnchor" id="H374254861"><span class="h2">Mark the site and side</span><span class="headingEndMark"> — </span>The patient should be examined in the perioperative holding area, and the correct breast to be removed should be identified, confirmed with the patient, and marked with a permanent skin marking pen. </p><p class="headingAnchor" id="H374254867"><span class="h2">Antibiotics</span><span class="headingEndMark"> — </span>A preoperative antibiotic that covers skin flora, such as <a class="drug drug_general" data-topicid="9214" href="/d/drug information/9214.html" rel="external">cefazolin</a>, should be administered within one hour before the incision is made  (<a class="graphic graphic_table graphicRef89540" href="/d/graphic/89540.html" rel="external">table 1</a>) [<a href="#rid45">45</a>]. (See  <a class="medical medical_review" href="/d/html/4043.html" rel="external">"Antimicrobial prophylaxis for prevention of surgical site infection in adults"</a>.)</p><p class="headingAnchor" id="H374254874"><span class="h2">Venous thromboembolism prophylaxis</span><span class="headingEndMark"> — </span>The American Society of Breast Surgeons suggests chemoprophylaxis for patients undergoing mastectomy with immediate reconstruction and/or general anesthesia for &gt;3 hours and chemoprophylaxis for those who are at high risk of developing thromboembolic events (eg, Caprini score &gt;5) [<a href="#rid46">46</a>]. Early ambulation and sequential compression devices are suggested for all other patients undergoing mastectomy. (See  <a class="medical medical_review" href="/d/html/1339.html" rel="external">"Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients"</a>.)</p><p class="headingAnchor" id="H374254881"><span class="h1">ANESTHESIA</span><span class="headingEndMark"> — </span>Mastectomy is usually performed under general anesthesia. Pectoral nerve blocks (Pecs) types I and II are commonly performed by an anesthesiologist before the procedure or by the surgeon during the procedure. They are a part of the multimodal analgesic strategy to reduce both postoperative narcotic requirement and postmastectomy pain syndrome. (See  <a class="medical medical_review" href="/d/html/86609.html" rel="external">"Postmastectomy pain syndrome: Risk reduction and management", section on 'Risk reduction'</a>.) </p><p>The technique of Pecs I and Pecs II blocks is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/100071.html" rel="external">"Thoracic nerve block techniques", section on 'Fascial plane blocks of the chest wall'</a>.)</p><p class="headingAnchor" id="H374254887"><span class="h1">SURGICAL TECHNIQUE</span></p><p class="headingAnchor" id="H374254893"><span class="h2">Positioning</span><span class="headingEndMark"> — </span>The patient is positioned supine with their arms extended on padded arm boards at ≤90 degrees abduction from the chest wall  (<a class="graphic graphic_figure graphicRef112650" href="/d/graphic/112650.html" rel="external">figure 2</a>). Arm positioning with &gt;90 degrees of abduction increases the potential for stretching the brachial plexus and should be avoided. It is important to position the arm while the patient is awake to make sure the arm is not abducted beyond what is comfortable for the patient, especially if there are preexisting problems with shoulder mobility. The ipsilateral arm can be included in the prepped field, which allows the arm to be mobilized during the procedure.</p><p class="headingAnchor" id="H374254899"><span class="h2">Axillary staging</span><span class="headingEndMark"> — </span>If the patient is having a sentinel lymph node biopsy, it should be performed before the mastectomy, which could disrupt the lymphatic flow. Sentinel lymph node biopsy or axillary lymph node dissection may be performed through the mastectomy incision or require a separate axillary incision, depending on whether adequate access to the axilla can be obtained through the mastectomy incision [<a href="#rid47">47</a>]. A study of 44 patients showed that the sentinel node biopsy could be removed via the breast incision in 98 percent of cases [<a href="#rid48">48</a>]. (See  <a class="medical medical_review" href="/d/html/805.html" rel="external">"Sentinel lymph node biopsy in breast cancer: Techniques"</a> and  <a class="medical medical_review" href="/d/html/14984.html" rel="external">"Technique of axillary lymph node dissection"</a>.) </p><p class="headingAnchor" id="H374254905"><span class="h2">Incisions</span><span class="headingEndMark"> — </span>The choice of incisions will depend upon tumor location, tumor size, and whether immediate reconstruction is planned. Given that skin-sparing mastectomy (SSM) and nipple-areolar-sparing mastectomy (NSM) are typically performed with immediate reconstruction, the incisions may be planned with the plastic surgeon. </p><p class="bulletIndent1"><span class="glyph">●</span>For a simple or modified radical mastectomy (MRM) without immediate reconstruction, the most common incision is a transverse or oblique elliptical incision including the nipple-areolar complex (NAC) with an appropriate skin paddle, with lateral extension toward the axilla  (<a class="graphic graphic_figure graphicRef59388" href="/d/graphic/59388.html" rel="external">figure 3</a>). However, if the tumor involves the skin, the incision may need to be adjusted according to the tumor location  (<a class="graphic graphic_figure graphicRef66661" href="/d/graphic/66661.html" rel="external">figure 4</a> and <a class="graphic graphic_figure graphicRef81050" href="/d/graphic/81050.html" rel="external">figure 5</a> and <a class="graphic graphic_figure graphicRef69254" href="/d/graphic/69254.html" rel="external">figure 6</a> and <a class="graphic graphic_figure graphicRef61564" href="/d/graphic/61564.html" rel="external">figure 7</a>). The incision should not be extended across the anterior axillary line to avoid scar contractures that could decrease the range of shoulder movement. The axillary lymph nodes are accessed through the mastectomy incision. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For an SSM, the incision may be a small ellipse around the NAC or a circular incision with or without a lateral extension if needed  (<a class="graphic graphic_figure graphicRef71134" href="/d/graphic/71134.html" rel="external">figure 8</a>). Sentinel node biopsy is sometimes performed through a separate axillary incision, though this is rarely necessary. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>NSM can be performed via a variety of incisions (inframammary, midlateral, circumareolar, or a combination) depending on patient anatomy and surgeon preference [<a href="#rid21">21,49,50</a>]. Circumareolar incision has been associated with a higher risk of nipple necrosis [<a href="#rid51">51</a>]. (See <a class="local">'Nipple necrosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A robot-assisted technique of NSM has been proposed but remains experimental [<a href="#rid52">52,53</a>]. </p><p></p><p class="headingAnchor" id="H374254911"><span class="h2">Skin flaps</span><span class="headingEndMark"> — </span>Skin flaps are raised superiorly to the level of the clavicle, inferiorly to the insertion of the rectus sheath, medially to the ipsilateral sternal border, and laterally to the latissimus dorsi muscle edge  (<a class="graphic graphic_figure graphicRef80257" href="/d/graphic/80257.html" rel="external">figure 9</a>). Flap thickness will vary with patient body habitus and technique used (eg, tumescent) but generally is approximately 7 to 8 mm thick. The flaps are raised in the plane deep to the subcutaneous tissue and superficial to the breast parenchyma, using scissors, scalpel, or electrocautery  (<a class="graphic graphic_figure graphicRef50156" href="/d/graphic/50156.html" rel="external">figure 10</a> and <a class="graphic graphic_figure graphicRef61995" href="/d/graphic/61995.html" rel="external">figure 11</a>) [<a href="#rid54">54-59</a>]. </p><p>An alternative method for creating skin flaps is the tumescent technique [<a href="#rid60">60</a>], which allows for potentially less blood loss. The subcutaneous tissue is infiltrated with 1 liter of <a class="drug drug_general" data-topicid="108196" href="/d/drug information/108196.html" rel="external">Lactated Ringer</a> solution mixed with 30 mL of 1% <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a> hydrochloride and 1 mL of dilute <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> (1:1000) [<a href="#rid61">61</a>]; the breast tissue is then sharply dissected from the subcutaneous tissue. Electrocautery is usually not used with this technique.</p><p class="headingAnchor" id="H1559817446"><span class="h2">Nipple margin assessment for NSM</span><span class="headingEndMark"> — </span>In NSM, it is particularly important to remove all of the breast tissue directly behind the nipple, taking care not to injury the nipple or compromise the blood supply. The tissue directly below the nipple is typically sent as a separate specimen ("nipple margin") to pathology for intraoperative frozen section [<a href="#rid21">21</a>]. The nipple must be removed if any carcinoma is identified [<a href="#rid16">16</a>]. However, these biopsies of the areola and nipple are not completely reliable in predicting occult involvement in patients with a breast cancer [<a href="#rid62">62-64</a>]. Although the intraoperative biopsy of the retroareolar margin must be histologically negative for malignancy, the precise measurement of a negative margin has not been defined. </p><p class="headingAnchor" id="H374254917"><span class="h2">Dissection from the chest wall</span><span class="headingEndMark"> — </span>The breast tissue is dissected off the muscle, using cautery to decrease bleeding from the muscle  (<a class="graphic graphic_figure graphicRef52804" href="/d/graphic/52804.html" rel="external">figure 12</a>). The pectoralis fascia is traditionally removed with the breast tissue in all modern mastectomies (MRM, simple, SSM, and NSM). A trial of 247 breast cancer patients undergoing mastectomy randomized patients between removal (n = 122) versus preservation (n = 125) of the pectoral fascia and reported a trend toward increased risk for chest wall recurrence when the fascia was preserved [<a href="#rid65">65</a>]. There were 18 chest wall recurrences in the pectoral fascia preservation group versus 10 in the pectoral fascia removal group (hazard ratio 1.8, 95% CI 0.8-4.0).</p><p>Tumor adherence to the muscle requires removal of that portion of the pectoris muscle with the breast specimen with a surrounding margin and placement of clips in anticipation of subsequent postmastectomy radiation therapy [<a href="#rid50">50</a>]. </p><p>It is important to remove the breast tissue that lies at the superior-lateral border where the pectoralis major muscle inserts into the humerus. When the lateral border of the breast is reached, the pectoralis muscle is gently retracted medially and the clavipectoral fascia incised to expose the axillary contents, and axillary dissection or sentinel lymph node biopsy can be performed if indicated. (See  <a class="medical medical_review" href="/d/html/14984.html" rel="external">"Technique of axillary lymph node dissection"</a>.)</p><p class="headingAnchor" id="H374254923"><span class="h2">Drains</span><span class="headingEndMark"> — </span>Closed suction drains are placed through separate stab wounds inferolateral to the main incision and sewn in place  (<a class="graphic graphic_figure graphicRef64558" href="/d/graphic/64558.html" rel="external">figure 13</a>). Generally, one drain is positioned beneath the inferior mastectomy skin flap, where it will best drain dependent fluid when the patient is upright. If an MRM is performed, a second drain is positioned into the axilla, trimmed so that it will not abrade the axillary vein. A second drain is not used if only a sentinel lymph node biopsy was performed. </p><p>The drains are left in place until the drainage of serous fluid has decreased to approximately 25 to 30 mL per drain per day for two consecutive days or when they have been in place for longer than 30 days. If the drains are removed too soon, a seroma may occur, which will require management with aspiration and/or placement of a seroma catheter [<a href="#rid66">66-69</a>]. (See <a class="local">'Seroma'</a> below.)</p><p class="headingAnchor" id="H374254929"><span class="h2">Closure</span><span class="headingEndMark"> — </span>The incisions are usually closed in two layers, using absorbable sutures. Prior to that, the flap may be fixed to the chest wall with sutures. Suture fixation of the flap has led to significantly fewer aspirations of postmastectomy seromas (7.3 versus 17.5 percent) in one trial [<a href="#rid70">70</a>].</p><p>The patient with obesity or large breasts will often have redundant tissue, which can result in an unsightly and uncomfortable "dog-ear" deformity at the axillary end of the incision. Various techniques have been described for addressing this, either at the time of primary surgery or as a staged procedure. </p><p>As an example, a "Y"-shaped incision can be used to excise excess skin and avoid this deformity [<a href="#rid71">71</a>]. Instead of suturing the full length of the wound, the medial one-half to two-thirds of the wound is first sutured using a subcuticular suturing technique  (<a class="graphic graphic_figure graphicRef64558" href="/d/graphic/64558.html" rel="external">figure 13</a> and <a class="graphic graphic_figure graphicRef63182" href="/d/graphic/63182.html" rel="external">figure 14</a>). The lateral tip of the incision is then approximated to the midline of the closure, excess skin is removed, and the final wound will be "Y" or "fish-tail" shaped with two "arms" facing toward the lateral side of the wound. In a study of 117 women who underwent mastectomy with a "Y"-shaped incision, the cosmetic outcome was improved and &lt;1 percent developed skin flap necrosis [<a href="#rid72">72</a>]. </p><p>Alternatively, two additional oblique incisions  (<a class="graphic graphic_figure graphicRef64558" href="/d/graphic/64558.html" rel="external">figure 13</a>) can be added to the traditional transverse elliptical incision at the lateral part of the mastectomy incision site. The resulting lateral triangular flap is advanced medially during the closure of the wound, and the redundant skin in the superior and inferior areas is excised.</p><p>For patients planning on delayed reconstruction, these incisions can complicate that reconstruction, and therefore it may be better to temporarily accept a dog-ear deformity until reconstruction, where it will be corrected. For patients who were considering delayed reconstruction but ultimately opt not to, any residual dog-ear deformity can subsequently be excised. </p><p class="headingAnchor" id="H374254941"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Major surgical complications can negatively impact breast cancer survival. In a large Swedish database study, major surgical complications (those requiring readmissions or reoperations within 30 days) were more common after mastectomy than breast-conserving surgery (7.3 versus 4.3 percent) [<a href="#rid73">73</a>]. Having a major postoperative complication is associated with worse 5-year overall survival (hazard ratio [HR] 1.32, 95% CI. 1.15 to 1.51) and breast cancer specific survival (HR 1.31, 95% CI 1.04 to 1.65). This correlation is most prominent among patients who undergo mastectomy without reconstruction. </p><p>Complications of mastectomy include seroma, wound infection, skin flap necrosis, nipple necrosis (following nipple-areolar-sparing mastectomy [NSM]), chest wall pain, phantom breast syndrome, and arm morbidity. </p><p class="headingAnchor" id="H374254947"><span class="h2">Seroma</span><span class="headingEndMark"> — </span>Seroma formation, a collection of serous fluid under the skin flaps, is commonly seen after breast and axillary surgery [<a href="#rid74">74,75</a>]. Untreated seroma formation results in delayed wound healing, wound infection, wound dehiscence, flap necrosis, delayed recovery, and poor cosmetic outcome [<a href="#rid76">76</a>]. The pathophysiology of seroma formation is poorly understood, but seroma formation is increased with obesity, extensive surgery, and the use of electrocautery for skin flap dissection [<a href="#rid77">77</a>]. Seromas are more likely to occur after mastectomy than with breast conservation [<a href="#rid78">78,79</a>]. </p><p>Drains are effective for seroma prevention in most cases because they obliterate the dead space between the skin flap and the pectoralis muscle (see <a class="local">'Drains'</a> above). Another method of reducing the dead space is by suturing the skin flaps to the underlying muscle, although this may compromise the cosmetic outcome and thus is rarely used [<a href="#rid75">75</a>]. Other techniques, such as sealants and sclerotherapy, <a class="drug drug_general" data-topicid="9986" href="/d/drug information/9986.html" rel="external">tetracycline</a>, fibrin glues, patches, and the use of external compression dressings, are generally not useful.</p><p>Vigorous postoperative shoulder exercises, as opposed to gentle range-of-motion exercises, can increase seroma formation. While patients are encouraged to use their arms normally postoperatively for activities of daily living such as brushing their hair or brushing their teeth, formal exercises should be postponed until the drains are removed and any seroma is resolved. A meta-analysis of six randomized trials showed that delaying formal exercises significantly decreased seroma formation (odds ratio 0.4; 95% CI 0.2-0.5) [<a href="#rid80">80</a>].</p><p class="headingAnchor" id="H374254953"><span class="h2">Wound infection</span><span class="headingEndMark"> — </span>The rates of postoperative wound infection after breast surgery are low because these are clean procedures [<a href="#rid81">81</a>]. As an example, the wound infection rate after breast surgery was 2.9 percent in a study of 1400 patients [<a href="#rid82">82</a>]. Obesity, smoking, older age, and diabetes mellitus have been identified to be associated with an increased risk of infection after breast surgery [<a href="#rid83">83</a>]. Smoking, in particular, increases the risk of wound infection fourfold after breast surgery [<a href="#rid84">84</a>]. (See  <a class="medical medical_review" href="/d/html/112216.html" rel="external">"Risk factors for impaired wound healing and wound complications"</a>.)</p><p>A meta-analysis of 2587 surgical breast procedures found a wound infection rate of 3.8 percent [<a href="#rid85">85</a>]. Most are staphylococcal infections, caused by skin flora. </p><p>Most postoperative cellulitis can be treated with oral antibiotics, but nonresponsive or extensive infection requires intravenous antibiotics. A small number of postoperative infections will develop into an abscess requiring drainage by reopening the original surgical incision.</p><p class="headingAnchor" id="H374254959"><span class="h2">Skin flap necrosis</span><span class="headingEndMark"> — </span>The rate of skin flap necrosis from modified radical mastectomy (MRM) or simple mastectomy is estimated at 10 to 18 percent [<a href="#rid86">86,87</a>]. Full-thickness skin flap necrosis requires surgical debridement and may require skin grafting and result in delays in adjuvant treatment and diminished cosmetic outcome [<a href="#rid88">88</a>]. Prior radiation treatment, obesity, older age, and a smoking history can increase the rates of flap necrosis. Technical methods of decreasing the risk of skin flap necrosis include minimizing the use of electric cautery method in dissection, maintaining appropriate skin flap thickness, and avoiding tension on closure of the incision.</p><p>The use of tumescence solution (ie, 1% <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a> with <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a>) injected into the subcutaneous tissue is associated with a higher risk of flap necrosis in some [<a href="#rid88">88,89</a>] but not all studies [<a href="#rid90">90</a>]. </p><p class="headingAnchor" id="H1663583306"><span class="h2">Nipple necrosis</span><span class="headingEndMark"> — </span>Nipple-areolar complex (NAC) necrosis is a complication that occurs after NSM. In a pooled analysis of 12,358 NSM procedures, the overall complication rate and nipple necrosis rate were 22 and 6 percent, respectively [<a href="#rid91">91</a>]. A prospective study of 59 prophylactic NSM reported a complete and partial nipple necrosis rate of 3 and 12 percent [<a href="#rid92">92</a>]. </p><p>Factors predisposing to nipple necrosis included large breast volume, ptotic breast, smoking, prior radiotherapy, and periareolar incision. The selection criteria for NSM are partially based on avoidance of these risk factors. (See <a class="local">'Nipple-areolar-sparing mastectomy'</a> above.)</p><p>The majority of the partial nipple necrosis (6.5 percent) and some complete nipple necrosis (2.9 percent) can be managed conservatively, though a small percentage warrant complete removal of the NAC [<a href="#rid18">18</a>]. </p><p>In a meta-analysis comparing NSM to skin-sparing mastectomy (SSM), the overall complication rate of NSM was higher than that of SSM (23 versus 14 percent), but the majority of this is attributable to a 15 percent nipple necrosis rate associated with NSM [<a href="#rid29">29</a>]. Rates of other complications (such as wound infection, skin loss, and implant loss) were not significantly different between NSM and other types of mastectomies. </p><p class="headingAnchor" id="H374254965"><span class="h2">Pain</span><span class="headingEndMark"> — </span>Burning, aching, and tight constriction of the axilla, upper arm, and chest wall with superimposed lancinations and scar sensitivity are characteristic of postmastectomy pain. In the past, fewer than 10 percent of patients undergoing mastectomy developed chronic pain [<a href="#rid93">93</a>]; subsequent surveys have reported chronic pain, paresthesias, and phantom sensations in up to one-half of cases [<a href="#rid94">94</a>]. This trend may be related to the radiation and chemotherapy, which are often needed in addition to surgery. Although the available data are scant, at least one long-term follow-up study suggests that approximately one-half of cases resolve over time, while the remainder persist long-term [<a href="#rid95">95</a>].</p><p>Factors that contribute to the development of postmastectomy pain include axillary dissection [<a href="#rid96">96</a>] and breast reconstruction with implants after mastectomy [<a href="#rid97">97</a>]. Submuscular implant placement can cause injury to the long thoracic, thoracodorsal, lateral-pectoral, and medial-pectoral nerves. Capsule formation around the implant also may entrap the long thoracic and the two pectoral nerves.</p><p>Evaluation of chest and arm pain after mastectomy should focus upon the nature of the pain and its location and a neurologic examination to define the areas of sensory loss and hypersensitivity. Pain that is not typical of postmastectomy pain syndrome should prompt evaluation for infection, tumor recurrence, or other causes of chest pain, such as cardiac, pulmonary, or esophageal disease. Progressively worsening pain should prompt suspicion for recurrent disease. </p><p>Postmastectomy pain syndrome is discussed in other dedicated topics. (See  <a class="medical medical_review" href="/d/html/14973.html" rel="external">"Clinical manifestations and diagnosis of postmastectomy pain syndrome"</a> and  <a class="medical medical_review" href="/d/html/86609.html" rel="external">"Postmastectomy pain syndrome: Risk reduction and management"</a>.)</p><p class="headingAnchor" id="H374254971"><span class="h2">Phantom breast syndrome</span><span class="headingEndMark"> — </span>Patients may describe a change in chest wall sensation after mastectomy sometimes described as "phantom breast syndrome" [<a href="#rid98">98</a>]. The sensation of residual breast tissue can persist for years after surgery [<a href="#rid99">99</a>]. The most common complaint is pain, but itching, nipple sensation, erotic sensations, and premenstrual-type breast soreness are also described.</p><p>Although the cause is unknown, psychologic factors related to mastectomy have been implicated [<a href="#rid98">98</a>]. Patient education before mastectomy, outlining the possible changes in chest wall sensation and the possibility of phantom breast syndrome, may help to relieve patient anxiety if symptoms develop and may even reduce the frequency of this syndrome.</p><p class="headingAnchor" id="H374254977"><span class="h2">Arm morbidity</span><span class="headingEndMark"> — </span>Arm morbidity is common after mastectomy (particularly modified radical mastectomy, which includes axillary lymph node dissection) and can include arm swelling, arm pain, arm numbness, arm stiffness, shoulder stiffness, shoulder pain, or nerve injury [<a href="#rid100">100</a>]. Postmastectomy radiation also contributes to arm morbidity and shoulder dysfunction. Complications of axillary surgery are discussed separately. (See  <a class="medical medical_review" href="/d/html/14984.html" rel="external">"Technique of axillary lymph node dissection", section on 'Complications'</a>.) </p><p>After breast cancer surgery, patients should be provided with rehabilitation services as needed and informed about methods to improve shoulder function and reduce the risk of lymphedema [<a href="#rid101">101-105</a>]. A randomized trial of 392 patients who underwent breast cancer surgery found that a structured exercise program improved upper limb function compared with usual care without any adverse effects; specifically, exercise lowered pain intensity and reduced upper limb disability symptoms at 12 months [<a href="#rid106">106</a>]. </p><p>Prevention and treatment of arm edema are discussed separately. (See  <a class="medical medical_review" href="/d/html/755.html" rel="external">"Clinical features and diagnosis of peripheral lymphedema"</a> and  <a class="medical medical_review" href="/d/html/738.html" rel="external">"Clinical staging and conservative management of peripheral lymphedema"</a>.)</p><p class="headingAnchor" id="H374254989"><span class="h2">Brachial plexopathy</span><span class="headingEndMark"> — </span>Patients can develop brachial plexopathy from a stretch injury caused by malpositioning in the operating room. This can be avoided by careful positioning and the use of padded armboards. (See <a class="local">'Positioning'</a> above and  <a class="medical medical_review" href="/d/html/5266.html" rel="external">"Brachial plexus syndromes"</a>.) </p><p class="headingAnchor" id="H374254995"><span class="h1">POSTMASTECTOMY RADIATION THERAPY</span><span class="headingEndMark"> — </span>Postmastectomy radiation is indicated for patients at high risk for local recurrence, such as T4 tumors and patients with positive margins and/or positive axillary lymph nodes. If postmastectomy radiation is likely, the choice of mastectomy type, choice of the reconstructive approach, and optimal timing of the breast reconstruction (immediate versus delayed) may be affected. Thus, <strong>preoperative</strong> coordination of care between the breast surgeon, the reconstructive surgeon, and the radiation oncologist assures the best outcome. Sentinel lymph node (SLN) biopsy prior to mastectomy is sometimes useful in helping to assess which patients will require postmastectomy radiotherapy. Postmastectomy radiation is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/801.html" rel="external">"Overview of breast reconstruction", section on 'Integrating radiation therapy and breast reconstruction'</a>.)</p><p class="headingAnchor" id="H374255001"><span class="h1">BREAST RECONSTRUCTION</span><span class="headingEndMark"> — </span>Most women undergoing mastectomy are candidates for immediate or delayed breast reconstruction. (See  <a class="medical medical_review" href="/d/html/801.html" rel="external">"Overview of breast reconstruction"</a>.)</p><p class="headingAnchor" id="H1658180572"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/119871.html" rel="external">"Society guideline links: Breast surgery"</a>.)</p><p><strong>INFORMATION FOR PATIENTS</strong> — UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/135267.html" rel="external">"Patient education: Seroma (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H374255007"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications for mastectomy</strong> – A therapeutic mastectomy is indicated for patients with a breast malignancy who are not candidates for breast-conserving therapy or who prefer mastectomy. A prophylactic, or risk-reducing, mastectomy is performed to reduce the risk of developing breast cancer. (See <a class="local">'Indications for mastectomy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mastectomy techniques</strong> – The choice of mastectomy depends on the clinical scenario (see <a class="local">'Choice of mastectomy'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients having a therapeutic mastectomy without immediate reconstruction, a modified radical mastectomy (MRM) or simple mastectomy is performed. An MRM includes axillary dissection and is utilized in patients who have biopsy-proven axillary lymph node metastases. Clinically node-negative patients should undergo simple mastectomy and sentinel lymph node biopsy instead. (See <a class="local">'Delayed or no reconstruction'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients having a therapeutic mastectomy with immediate reconstruction, a skin-sparing mastectomy (SSM) or nipple-areolar-sparing mastectomy (NSM) may be considered. The decisions regarding how much skin to preserve, whether the nipple-areolar complex (NAC) can be spared or removed, and the appropriate incisions to use require coordination between the breast surgeon and the plastic surgeon. Both SSM and NSM are contraindicated in patients with inflammatory breast cancer. NSM is also contraindicated in those with clinical involvement of the NAC, nipple retraction, Paget disease, or bloody nipple discharge. (See <a class="local">'Immediate reconstruction'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients having mastectomy for prophylactic purposes who desire reconstruction, either an SSM or NSM may provide good cosmetic results. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications of mastectomy</strong> – Complications after mastectomy include seroma, wound infection, skin flap necrosis, nipple necrosis (mostly after NSM), chest wall pain, phantom breast syndrome, and arm morbidity. Major surgical complications can negatively impact breast cancer survival. (See <a class="local">'Complications'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Wong SM, Freedman RA, Sagara Y, et al. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer. Ann Surg 2016.</a></li><li class="breakAll">National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology (NCCN Guidelines). Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic. Version 1.2020 - December 4, 2019. Available at: https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf (Accessed on May 13, 2020).</li><li><a class="nounderline abstract_t">Jatoi I, Kemp Z. Risk-Reducing Mastectomy. JAMA 2021; 325:1781.</a></li><li><a class="nounderline abstract_t">Munhoz AM, Montag E, Filassi JR, Gemperli R. Immediate nipple-areola-sparing mastectomy reconstruction: An update on oncological and reconstruction techniques. World J Clin Oncol 2014; 5:478.</a></li><li><a class="nounderline abstract_t">Turner L, Swindell R, Bell WG, et al. Radical versus modified radical mastectomy for breast cancer. Ann R Coll Surg Engl 1981; 63:239.</a></li><li><a class="nounderline abstract_t">Maddox WA, Carpenter JT Jr, Laws HL, et al. A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients. Ann Surg 1983; 198:207.</a></li><li><a class="nounderline abstract_t">Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312:674.</a></li><li><a class="nounderline abstract_t">Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002; 347:567.</a></li><li><a class="nounderline abstract_t">Cuzick J, Stewart H, Peto R, et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 1987; 71:15.</a></li><li><a class="nounderline abstract_t">Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994; 12:447.</a></li><li><a class="nounderline abstract_t">Toth BA, Lappert P. Modified skin incisions for mastectomy: the need for plastic surgical input in preoperative planning. Plast Reconstr Surg 1991; 87:1048.</a></li><li><a class="nounderline abstract_t">Baildam AD. Skin-sparing mastectomy. Eur J Cancer 2011; 47 Suppl 3:S342.</a></li><li><a class="nounderline abstract_t">Warren Peled A, Foster RD, Stover AC, et al. Outcomes after total skin-sparing mastectomy and immediate reconstruction in 657 breasts. Ann Surg Oncol 2012; 19:3402.</a></li><li><a class="nounderline abstract_t">Lanitis S, Tekkis PP, Sgourakis G, et al. Comparison of skin-sparing mastectomy versus non-skin-sparing mastectomy for breast cancer: a meta-analysis of observational studies. Ann Surg 2010; 251:632.</a></li><li><a class="nounderline abstract_t">Dawood S, Merajver SD, Viens P, et al. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol 2011; 22:515.</a></li><li><a class="nounderline abstract_t">Chung AP, Sacchini V. Nipple-sparing mastectomy: where are we now? Surg Oncol 2008; 17:261.</a></li><li><a class="nounderline abstract_t">Simmons RM, Hollenbeck ST, Latrenta GS. Areola-sparing mastectomy with immediate breast reconstruction. Ann Plast Surg 2003; 51:547.</a></li><li><a class="nounderline abstract_t">Mallon P, Feron JG, Couturaud B, et al. The role of nipple-sparing mastectomy in breast cancer: a comprehensive review of the literature. Plast Reconstr Surg 2013; 131:969.</a></li><li><a class="nounderline abstract_t">Agarwal S, Agarwal S, Neumayer L, Agarwal JP. Therapeutic nipple-sparing mastectomy: trends based on a national cancer database. Am J Surg 2014; 208:93.</a></li><li><a class="nounderline abstract_t">Valero MG, Muhsen S, Moo TA, et al. Increase in Utilization of Nipple-Sparing Mastectomy for Breast Cancer: Indications, Complications, and Oncologic Outcomes. Ann Surg Oncol 2020; 27:344.</a></li><li><a class="nounderline abstract_t">Kopkash K, Sisco M, Poli E, et al. The modern approach to the nipple-sparing mastectomy. J Surg Oncol 2020; 122:29.</a></li><li><a class="nounderline abstract_t">Spear SL, Hannan CM, Willey SC, Cocilovo C. Nipple-sparing mastectomy. Plast Reconstr Surg 2009; 123:1665.</a></li><li><a class="nounderline abstract_t">Tokin C, Weiss A, Wang-Rodriguez J, Blair SL. Oncologic safety of skin-sparing and nipple-sparing mastectomy: a discussion and review of the literature. Int J Surg Oncol 2012; 2012:921821.</a></li><li><a class="nounderline abstract_t">Fortunato L, Loreti A, Andrich R, et al. When mastectomy is needed: is the nipple-sparing procedure a new standard with very few contraindications? J Surg Oncol 2013; 108:207.</a></li><li><a class="nounderline abstract_t">de Alcantara Filho P, Capko D, Barry JM, et al. Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience. Ann Surg Oncol 2011; 18:3117.</a></li><li><a class="nounderline abstract_t">Gerber B, Krause A, Dieterich M, et al. The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study. Ann Surg 2009; 249:461.</a></li><li><a class="nounderline abstract_t">Murthy V, Chamberlain RS. Defining a place for nipple sparing mastectomy in modern breast care: an evidence based review. Breast J 2013; 19:571.</a></li><li><a class="nounderline abstract_t">Wu ZY, Kim HJ, Lee JW, et al. Breast Cancer Recurrence in the Nipple-Areola Complex After Nipple-Sparing Mastectomy With Immediate Breast Reconstruction for Invasive Breast Cancer. JAMA Surg 2019; 154:1030.</a></li><li><a class="nounderline abstract_t">Agha RA, Al Omran Y, Wellstead G, et al. Systematic review of therapeutic nipple-sparing versus skin-sparing mastectomy. BJS Open 2019; 3:135.</a></li><li><a class="nounderline abstract_t">De La Cruz L, Moody AM, Tappy EE, et al. Overall Survival, Disease-Free Survival, Local Recurrence, and Nipple-Areolar Recurrence in the Setting of Nipple-Sparing Mastectomy: A Meta-Analysis and Systematic Review. Ann Surg Oncol 2015; 22:3241.</a></li><li><a class="nounderline abstract_t">Jakub JW, Peled AW, Gray RJ, et al. Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study. JAMA Surg 2018; 153:123.</a></li><li><a class="nounderline abstract_t">Peled AW, Irwin CS, Hwang ES, et al. Total skin-sparing mastectomy in BRCA mutation carriers. Ann Surg Oncol 2014; 21:37.</a></li><li><a class="nounderline abstract_t">Manning AT, Wood C, Eaton A, et al. Nipple-sparing mastectomy in patients with BRCA1/2 mutations and variants of uncertain significance. Br J Surg 2015; 102:1354.</a></li><li><a class="nounderline abstract_t">Valero MG, Moo TA, Muhsen S, et al. Use of bilateral prophylactic nipple-sparing mastectomy in patients with high risk of breast cancer. Br J Surg 2020; 107:1307.</a></li><li><a class="nounderline abstract_t">Moyer HR, Ghazi B, Daniel JR, et al. Nipple-sparing mastectomy: technical aspects and aesthetic outcomes. Ann Plast Surg 2012; 68:446.</a></li><li><a class="nounderline abstract_t">Wei CH, Scott AM, Price AN, et al. Psychosocial and Sexual Well-Being Following Nipple-Sparing Mastectomy and Reconstruction. Breast J 2016; 22:10.</a></li><li><a class="nounderline abstract_t">Gahm J, Hansson P, Brandberg Y, Wickman M. Breast sensibility after bilateral risk-reducing mastectomy and immediate breast reconstruction: a prospective study. J Plast Reconstr Aesthet Surg 2013; 66:1521.</a></li><li><a class="nounderline abstract_t">Niemeyer M, Paepke S, Schmid R, et al. Extended indications for nipple-sparing mastectomy. Breast J 2011; 17:296.</a></li><li class="breakAll">National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology (NCCN Guidelines). Breast cancer. Version 4.2020 - May 8, 2020. Available at: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf (Accessed on May 14, 2020).</li><li><a class="nounderline abstract_t">Tousimis E, Haslinger M. Overview of indications for nipple sparing mastectomy. Gland Surg 2018; 7:288.</a></li><li><a class="nounderline abstract_t">Halsted WS. I. The Results of Radical Operations for the Cure of Carcinoma of the Breast. Ann Surg 1907; 46:1.</a></li><li><a class="nounderline abstract_t">Adair F, Berg J, Joubert L, Robbins GF. Long-term followup of breast cancer patients: the 30-year report. Cancer 1974; 33:1145.</a></li><li><a class="nounderline abstract_t">TURNER-WARWICK RT. The lymphatics of the breast. Br J Surg 1959; 46:574.</a></li><li><a class="nounderline abstract_t">Veronesi U, Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 1981; 47:170.</a></li><li class="breakAll">American Society of Breast Surgeons (ASBrS). Consensus guideline on preoperative antibiotics and surgical site infection in breast surgery. Approved 2017. Available at: https://www.breastsurgeons.org/docs/statements/Consensus-Guideline-on-Preoperative-Antibiotics-and-Surgical-Site-Infection-in-Breast-Surgery.pdf (Accessed on June 02, 2020).</li><li class="breakAll">American Society of Breast Surgeons (ASBrS). Consensus guideline on venous thromboembolism (VTE) prophylaxis for patients undergoing breast operations. Approved 2016. Available at: https://www.breastsurgeons.org/docs/statements/Consensus-Guideline-on-Venous-Thromboembolism-VTE-Prophylaxis-for-Patients-Undergoing-Breast-Operations.pdf (Accessed on June 02, 2020).</li><li><a class="nounderline abstract_t">Sabel MS, Degnim A, Wilkins EG, et al. Mastectomy and concomitant sentinel lymph node biopsy for invasive breast cancer. Am J Surg 2004; 187:673.</a></li><li><a class="nounderline abstract_t">Cocilovo C, Boolbol SK, Valdes E, Feldman S. Less is more: transmammary axillary lymph node evaluation: an initial clinical experience. Am J Surg 2006; 192:478.</a></li><li><a class="nounderline abstract_t">Blechman KM, Karp NS, Levovitz C, et al. The lateral inframammary fold incision for nipple-sparing mastectomy: outcomes from over 50 immediate implant-based breast reconstructions. Breast J 2013; 19:31.</a></li><li class="breakAll">American Society of Breast Surgeons (ASBrS). Performance and practice guidelines for mastectomy. 2018. Available at: https://www.breastsurgeons.org/docs/statements/Performance-and-Practice-Guidelines-for-Mastectomy.pdf (Accessed on May 14, 2020).</li><li><a class="nounderline abstract_t">Margenthaler JA, Gan C, Yan Y, et al. Oncologic Safety and Outcomes in Patients Undergoing Nipple-Sparing Mastectomy. J Am Coll Surg 2020; 230:535.</a></li><li><a class="nounderline abstract_t">Angarita FA, Castelo M, Englesakis M, et al. Robot-assisted nipple-sparing mastectomy: systematic review. Br J Surg 2020; 107:1580.</a></li><li><a class="nounderline abstract_t">Morrow M. Robotic mastectomy: the next major advance in breast cancer surgery? Br J Surg 2021; 108:233.</a></li><li><a class="nounderline abstract_t">Manouras A, Markogiannakis H, Genetzakis M, et al. Modified radical mastectomy with axillary dissection using the electrothermal bipolar vessel sealing system. Arch Surg 2008; 143:575.</a></li><li><a class="nounderline abstract_t">Kontos M, Kothari A, Hamed H. Effect of harmonic scalpel on seroma formation following surgery for breast cancer: a prospective randomized study. J BUON 2008; 13:223.</a></li><li><a class="nounderline abstract_t">Bandi G, Wen CC, Wilkinson EA, et al. Comparison of blade temperature dynamics after activation of Harmonic Ace scalpel and the Ultracision Harmonic Scalpel LCS-K5. J Endourol 2008; 22:333.</a></li><li><a class="nounderline abstract_t">Sanguinetti A, Docimo G, Ragusa M, et al. Ultrasound scissors versus electrocautery in axillary dissection: our experience. G Chir 2010; 31:151.</a></li><li><a class="nounderline abstract_t">Galatius H, Okholm M, Hoffmann J. Mastectomy using ultrasonic dissection: effect on seroma formation. Breast 2003; 12:338.</a></li><li><a class="nounderline abstract_t">Robertson SA, Rusby JE, Cutress RI. Determinants of optimal mastectomy skin flap thickness. Br J Surg 2014; 101:899.</a></li><li><a class="nounderline abstract_t">Staradub VL, Morrow M. Modified radical mastectomy with knife technique. Arch Surg 2002; 137:105.</a></li><li><a class="nounderline abstract_t">Carlson GW. Total mastectomy under local anesthesia: the tumescent technique. Breast J 2005; 11:100.</a></li><li><a class="nounderline abstract_t">Eisenberg RE, Chan JS, Swistel AJ, Hoda SA. Pathological evaluation of nipple-sparing mastectomies with emphasis on occult nipple involvement: the Weill-Cornell experience with 325 cases. Breast J 2014; 20:15.</a></li><li><a class="nounderline abstract_t">Camp MS, Coopey SB, Tang R, et al. Management of positive sub-areolar/nipple duct margins in nipple-sparing mastectomies. Breast J 2014; 20:402.</a></li><li><a class="nounderline abstract_t">D'Alonzo M, Pecchio S, Campisi P, et al. Nipple-Sparing Mastectomy: Reliability of sub-areolar sampling and frozen section in predicting occult nipple involvement in breast cancer patients. Eur J Surg Oncol 2018; 44:1736.</a></li><li><a class="nounderline abstract_t">Dalberg K, Krawiec K, Sandelin K. Eleven-year follow-up of a randomized study of pectoral fascia preservation after mastectomy for early breast cancer. World J Surg 2010; 34:2539.</a></li><li><a class="nounderline abstract_t">Barton A, Blitz M, Callahan D, et al. Early removal of postmastectomy drains is not beneficial: results from a halted randomized controlled trial. Am J Surg 2006; 191:652.</a></li><li><a class="nounderline abstract_t">Chintamani, Singhal V, Singh J, et al. Half versus full vacuum suction drainage after modified radical mastectomy for breast cancer- a prospective randomized clinical trial[ISRCTN24484328]. BMC Cancer 2005; 5:11.</a></li><li><a class="nounderline abstract_t">Dalberg K, Johansson H, Signomklao T, et al. A randomised study of axillary drainage and pectoral fascia preservation after mastectomy for breast cancer. Eur J Surg Oncol 2004; 30:602.</a></li><li><a class="nounderline abstract_t">Kopelman D, Klemm O, Bahous H, et al. Postoperative suction drainage of the axilla: for how long? Prospective randomised trial. Eur J Surg 1999; 165:117.</a></li><li><a class="nounderline abstract_t">de Rooij L, van Kuijk SMJ, Granzier RWY, et al. Reducing Seroma Formation and Its Sequelae After Mastectomy by Closure of the Dead Space: A Multi-center, Double-Blind Randomized Controlled Trial (SAM-Trial). Ann Surg Oncol 2021; 28:2599.</a></li><li><a class="nounderline abstract_t">Farrar WB, Fanning WJ. Eliminating the dog-ear in modified radical mastectomy. Am J Surg 1988; 156:401.</a></li><li><a class="nounderline abstract_t">Szynglarewicz B, Matkowski R, Kasprzak P, et al. Mastectomy approach with Y-shaped incision: a technique designed for women with obesity. Int J Gynecol Cancer 2009; 19:1454.</a></li><li><a class="nounderline abstract_t">de Boniface J, Szulkin R, Johansson ALV. Major surgical postoperative complications and survival in breast cancer: Swedish population-based register study in 57 152 women. Br J Surg 2022; 109:977.</a></li><li><a class="nounderline abstract_t">Boostrom SY, Throckmorton AD, Boughey JC, et al. Incidence of clinically significant seroma after breast and axillary surgery. J Am Coll Surg 2009; 208:148.</a></li><li><a class="nounderline abstract_t">van Bemmel AJ, van de Velde CJ, Schmitz RF, Liefers GJ. Prevention of seroma formation after axillary dissection in breast cancer: a systematic review. Eur J Surg Oncol 2011; 37:829.</a></li><li><a class="nounderline abstract_t">Agrawal A, Ayantunde AA, Cheung KL. Concepts of seroma formation and prevention in breast cancer surgery. ANZ J Surg 2006; 76:1088.</a></li><li><a class="nounderline abstract_t">Pogson CJ, Adwani A, Ebbs SR. Seroma following breast cancer surgery. Eur J Surg Oncol 2003; 29:711.</a></li><li><a class="nounderline abstract_t">Gonzalez EA, Saltzstein EC, Riedner CS, Nelson BK. Seroma formation following breast cancer surgery. Breast J 2003; 9:385.</a></li><li><a class="nounderline abstract_t">Hashemi E, Kaviani A, Najafi M, et al. Seroma formation after surgery for breast cancer. World J Surg Oncol 2004; 2:44.</a></li><li><a class="nounderline abstract_t">Shamley DR, Barker K, Simonite V, Beardshaw A. Delayed versus immediate exercises following surgery for breast cancer: a systematic review. Breast Cancer Res Treat 2005; 90:263.</a></li><li><a class="nounderline abstract_t">Chatzidaki P, Mellos C, Briese V, Mylonas I. Perioperative complications of breast cancer surgery in elderly women (≥80 years). Ann Surg Oncol 2011; 18:923.</a></li><li><a class="nounderline abstract_t">Sanguinetti A, Rosato L, Cirocchi R, et al. [Antibiotic prophylaxis in breast surgery. Preliminary resuls of a multicenter randomized study on 1400 cases]. Ann Ital Chir 2009; 80:275.</a></li><li><a class="nounderline abstract_t">Vitug AF, Newman LA. Complications in breast surgery. Surg Clin North Am 2007; 87:431.</a></li><li><a class="nounderline abstract_t">Sørensen LT, Hørby J, Friis E, et al. Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol 2002; 28:815.</a></li><li><a class="nounderline abstract_t">Platt R, Zucker JR, Zaleznik DF, et al. Perioperative antibiotic prophylaxis and wound infection following breast surgery. J Antimicrob Chemother 1993; 31 Suppl B:43.</a></li><li><a class="nounderline abstract_t">Carlson GW, Bostwick J 3rd, Styblo TM, et al. Skin-sparing mastectomy. Oncologic and reconstructive considerations. Ann Surg 1997; 225:570.</a></li><li><a class="nounderline abstract_t">Rao R, Saint-Cyr M, Ma AM, et al. Prediction of post-operative necrosis after mastectomy: a pilot study utilizing optical diffusion imaging spectroscopy. World J Surg Oncol 2009; 7:91.</a></li><li><a class="nounderline abstract_t">Chun YS, Verma K, Rosen H, et al. Use of tumescent mastectomy technique as a risk factor for native breast skin flap necrosis following immediate breast reconstruction. Am J Surg 2011; 201:160.</a></li><li><a class="nounderline abstract_t">Abbott AM, Miller BT, Tuttle TM. Outcomes after tumescence technique versus electrocautery mastectomy. Ann Surg Oncol 2012; 19:2607.</a></li><li><a class="nounderline abstract_t">Khavanin N, Fine NA, Bethke KP, et al. Tumescent technique does not increase the risk of complication following mastectomy with immediate reconstruction. Ann Surg Oncol 2014; 21:384.</a></li><li><a class="nounderline abstract_t">Headon HL, Kasem A, Mokbel K. The Oncological Safety of Nipple-Sparing Mastectomy: A Systematic Review of the Literature with a Pooled Analysis of 12,358 Procedures. Arch Plast Surg 2016; 43:328.</a></li><li><a class="nounderline abstract_t">Houvenaeghel G, Cohen M, Dammacco MA, et al. Prophylactic nipple-sparing mastectomy with immediate breast reconstruction: results of a French prospective trial. Br J Surg 2021; 108:296.</a></li><li><a class="nounderline abstract_t">Elliott K, Foley KM. Neurologic pain syndromes in patients with cancer. Crit Care Clin 1990; 6:393.</a></li><li><a class="nounderline abstract_t">Tasmuth T, von Smitten K, Hietanen P, et al. Pain and other symptoms after different treatment modalities of breast cancer. Ann Oncol 1995; 6:453.</a></li><li><a class="nounderline abstract_t">Macdonald L, Bruce J, Scott NW, et al. Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer 2005; 92:225.</a></li><li><a class="nounderline abstract_t">Maunsell E, Brisson J, Deschênes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993; 36:315.</a></li><li><a class="nounderline abstract_t">Wallace MS, Wallace AM, Lee J, Dobke MK. Pain after breast surgery: a survey of 282 women. Pain 1996; 66:195.</a></li><li><a class="nounderline abstract_t">Jamison K, Wellisch DK, Katz RL, Pasnau RO. Phantom breast syndrome. Arch Surg 1979; 114:93.</a></li><li><a class="nounderline abstract_t">Krøner K, Knudsen UB, Lundby L, Hvid H. Long-term phantom breast syndrome after mastectomy. Clin J Pain 1992; 8:346.</a></li><li><a class="nounderline abstract_t">Arndt V, Merx H, Stegmaier C, et al. Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer. J Clin Oncol 2005; 23:4945.</a></li><li><a class="nounderline abstract_t">Sclafani LM, Baron RH. Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction. Cancer J 2008; 14:216.</a></li><li><a class="nounderline abstract_t">Cave J, Jones A. Physiotherapy improves shoulder function after treatment in women with early breast cancer. Cancer Treat Rev 2006; 32:398.</a></li><li><a class="nounderline abstract_t">de Rezende LF, Franco RL, de Rezende MF, et al. Two exercise schemes in postoperative breast cancer: comparison of effects on shoulder movement and lymphatic disturbance. Tumori 2006; 92:55.</a></li><li><a class="nounderline abstract_t">Beurskens CH, van Uden CJ, Strobbe LJ, et al. The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study. BMC Cancer 2007; 7:166.</a></li><li><a class="nounderline abstract_t">Torres Lacomba M, Yuste Sánchez MJ, Zapico Goñi A, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ 2010; 340:b5396.</a></li><li><a class="nounderline abstract_t">Bruce J, Mazuquin B, Canaway A, et al. Exercise versus usual care after non-reconstructive breast cancer surgery (UK PROSPER): multicentre randomised controlled trial and economic evaluation. BMJ 2021; 375:e066542.</a></li></ol></div><div id="topicVersionRevision">Topic 14981 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26967636" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26967636" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33944884" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Risk-Reducing Mastectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25114861" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Immediate nipple-areola-sparing mastectomy reconstruction: An update on oncological and reconstruction techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7247286" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Radical versus modified radical mastectomy for breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6870379" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3883168" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12192016" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2856861" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8120544" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1852020" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Modified skin incisions for mastectomy: the need for plastic surgical input in preoperative planning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21944008" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Skin-sparing mastectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22526909" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Outcomes after total skin-sparing mastectomy and immediate reconstruction in 657 breasts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20224371" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Comparison of skin-sparing mastectomy versus non-skin-sparing mastectomy for breast cancer: a meta-analysis of observational studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20603440" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18456492" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Nipple-sparing mastectomy: where are we now?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14646645" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Areola-sparing mastectomy with immediate breast reconstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23629079" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The role of nipple-sparing mastectomy in breast cancer: a comprehensive review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24581994" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Therapeutic nipple-sparing mastectomy: trends based on a national cancer database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31823173" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Increase in Utilization of Nipple-Sparing Mastectomy for Breast Cancer: Indications, Complications, and Oncologic Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32219847" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The modern approach to the nipple-sparing mastectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19483564" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Nipple-sparing mastectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22848803" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Oncologic safety of skin-sparing and nipple-sparing mastectomy: a discussion and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23913775" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : When mastectomy is needed: is the nipple-sparing procedure a new standard with very few contraindications?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21847697" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19247035" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22284266" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Defining a place for nipple sparing mastectomy in modern breast care: an evidence based review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31461141" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Breast Cancer Recurrence in the Nipple-Areola Complex After Nipple-Sparing Mastectomy With Immediate Breast Reconstruction for Invasive Breast Cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30957059" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Systematic review of therapeutic nipple-sparing versus skin-sparing mastectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26242363" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Overall Survival, Disease-Free Survival, Local Recurrence, and Nipple-Areolar Recurrence in the Setting of Nipple-Sparing Mastectomy: A Meta-Analysis and Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28903167" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23982256" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Total skin-sparing mastectomy in BRCA mutation carriers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26313374" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Nipple-sparing mastectomy in patients with BRCA1/2 mutations and variants of uncertain significance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32432359" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Use of bilateral prophylactic nipple-sparing mastectomy in patients with high risk of breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22531398" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Nipple-sparing mastectomy: technical aspects and aesthetic outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26782950" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Psychosocial and Sexual Well-Being Following Nipple-Sparing Mastectomy and Reconstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23953096" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Breast sensibility after bilateral risk-reducing mastectomy and immediate breast reconstruction: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21450018" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Extended indications for nipple-sparing mastectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21450018" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Extended indications for nipple-sparing mastectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29998078" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Overview of indications for nipple sparing mastectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17861990" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : I. The Results of Radical Operations for the Cure of Carcinoma of the Breast.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4819216" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Long-term followup of breast cancer patients: the 30-year report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13839973" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The lymphatics of the breast.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7459805" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Inefficacy of internal mammary nodes dissection in breast cancer surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7459805" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Inefficacy of internal mammary nodes dissection in breast cancer surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7459805" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Inefficacy of internal mammary nodes dissection in breast cancer surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15191855" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Mastectomy and concomitant sentinel lymph node biopsy for invasive breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16978953" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Less is more: transmammary axillary lymph node evaluation: an initial clinical experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23252505" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : The lateral inframammary fold incision for nipple-sparing mastectomy: outcomes from over 50 immediate implant-based breast reconstructions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23252505" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The lateral inframammary fold incision for nipple-sparing mastectomy: outcomes from over 50 immediate implant-based breast reconstructions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32032724" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Oncologic Safety and Outcomes in Patients Undergoing Nipple-Sparing Mastectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32846014" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Robot-assisted nipple-sparing mastectomy: systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33723570" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Robotic mastectomy: the next major advance in breast cancer surgery?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18559751" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Modified radical mastectomy with axillary dissection using the electrothermal bipolar vessel sealing system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18555469" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Effect of harmonic scalpel on seroma formation following surgery for breast cancer: a prospective randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18294041" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Comparison of blade temperature dynamics after activation of Harmonic Ace scalpel and the Ultracision Harmonic Scalpel LCS-K5.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20444331" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Ultrasound scissors versus electrocautery in axillary dissection: our experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14659149" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Mastectomy using ultrasonic dissection: effect on seroma formation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24664617" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Determinants of optimal mastectomy skin flap thickness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11772228" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Modified radical mastectomy with knife technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15730454" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Total mastectomy under local anesthesia: the tumescent technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24438063" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Pathological evaluation of nipple-sparing mastectomies with emphasis on occult nipple involvement: the Weill-Cornell experience with 325 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24890641" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Management of positive sub-areolar/nipple duct margins in nipple-sparing mastectomies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30100362" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Nipple-Sparing Mastectomy: Reliability of sub-areolar sampling and frozen section in predicting occult nipple involvement in breast cancer patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20730429" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Eleven-year follow-up of a randomized study of pectoral fascia preservation after mastectomy for early breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16647354" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Early removal of postmastectomy drains is not beneficial: results from a halted randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15676064" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Half versus full vacuum suction drainage after modified radical mastectomy for breast cancer- a prospective randomized clinical trial[ISRCTN24484328].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15256232" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : A randomised study of axillary drainage and pectoral fascia preservation after mastectomy for breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10192568" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Postoperative suction drainage of the axilla: for how long? Prospective randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33078318" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Reducing Seroma Formation and Its Sequelae After Mastectomy by Closure of the Dead Space: A Multi-center, Double-Blind Randomized Controlled Trial (SAM-Trial).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3189710" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Eliminating the dog-ear in modified radical mastectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20009906" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Mastectomy approach with Y-shaped incision: a technique designed for women with obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35929050" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Major surgical postoperative complications and survival in breast cancer: Swedish population-based register study in 57 152 women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19228516" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Incidence of clinically significant seroma after breast and axillary surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21849243" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Prevention of seroma formation after axillary dissection in breast cancer: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17199696" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Concepts of seroma formation and prevention in breast cancer surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14602488" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Seroma following breast cancer surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12968958" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Seroma formation following breast cancer surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15588301" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Seroma formation after surgery for breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15830140" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Delayed versus immediate exercises following surgery for breast cancer: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21107743" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Perioperative complications of breast cancer surgery in elderly women (≥80 years).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19967885" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : [Antibiotic prophylaxis in breast surgery. Preliminary resuls of a multicenter randomized study on 1400 cases].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17498536" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Complications in breast surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12477471" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Smoking as a risk factor for wound healing and infection in breast cancer surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8449845" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Perioperative antibiotic prophylaxis and wound infection following breast surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9193184" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Skin-sparing mastectomy. Oncologic and reconstructive considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19939277" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Prediction of post-operative necrosis after mastectomy: a pilot study utilizing optical diffusion imaging spectroscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20409522" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Use of tumescent mastectomy technique as a risk factor for native breast skin flap necrosis following immediate breast reconstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22402814" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Outcomes after tumescence technique versus electrocautery mastectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24121881" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Tumescent technique does not increase the risk of complication following mastectomy with immediate reconstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27462565" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : The Oncological Safety of Nipple-Sparing Mastectomy: A Systematic Review of the Literature with a Pooled Analysis of 12,358 Procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33793719" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Prophylactic nipple-sparing mastectomy with immediate breast reconstruction: results of a French prospective trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2188710" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Neurologic pain syndromes in patients with cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7669710" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Pain and other symptoms after different treatment modalities of breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15655557" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8370012" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Arm problems and psychological distress after surgery for breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8880841" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Pain after breast surgery: a survey of 282 women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/758885" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Phantom breast syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1493345" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Long-term phantom breast syndrome after mastectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16051947" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18677128" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16725266" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Physiotherapy improves shoulder function after treatment in women with early breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16683384" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Two exercise schemes in postoperative breast cancer: comparison of effects on shoulder movement and lymphatic disturbance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17760981" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20068255" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34759002" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Exercise versus usual care after non-reconstructive breast cancer surgery (UK PROSPER): multicentre randomised controlled trial and economic evaluation.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
